Filing Details
- Accession Number:
- 0001062993-23-022658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-15 17:33:22
- Reporting Period:
- 2023-12-14
- Accepted Time:
- 2023-12-15 17:33:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
720154 | Inotiv Inc. | NOTV | Services-Commercial Physical & Biological Research (8731) | 351345024 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1845679 | Gregory John Beattie | 2701 Kent Avenue West Lafayette IN 47906-1382 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-12-14 | 47,966 | $3.12 | 111,761 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2023-12-15 | 7,500 | $0.00 | 7,500 | $3.09 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,500 | 2033-12-15 | No | 4 | A | Direct |
Footnotes
- Reflects the weighted average price of 47,966 common shares purchased by the reporting person in multiple transactions on December 14, 2023 with purchase prices ranging from $2.88 to 3.30 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Represents a grant of non-qualified options, which have a three year vesting period of 40% / 30% / 30% beginning on the first anniversary of the grant date, subject to continued employment.